The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

The University of Kansas Cancer Center
J

HaploSCT: Choosing an Optimal Donor and Novel Strategies to Mitigate Post-HaploSCT Relapse and Improve Immune Reconstitution

By The University of Kansas Cancer Center FEATURING Joseph McGuirk
By The University of Kansas Cancer Center FEATURING Joseph McGuirk
28 views
June 2, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Advances in Hematologic Malignancies and Cellular Therapeutics Symposium
40:05

Mitigating Toxicities Associated With CAR T-Cell Therapies

The University of Kansas Cancer Center

S. Kenderian

14 views
30:52

Treatment of Aggressive B-Cell Lymphoma: SCT vs. CAR-T

The University of Kansas Cancer Center

M. Hamadani

59 views
30:18

Survivorship and Late Effects After Stem Cell Transplantation and CA…

The University of Kansas Cancer Center

N. Ahmed

33 views
41:31

HaploSCT: Choosing an Optimal Donor and Novel Strategies to Mitigate…

The University of Kansas Cancer Center

J. McGuirk

28 views
43:41

Prevention and Treatment of Disease Relapse After Allogeneic HCT

The University of Kansas Cancer Center

R. Soiffer

30:51

Preventing Post-Transplant Relapse With Targeted Therapies

The University of Kansas Cancer Center

M. Levis